Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gordon Sussman Clinical Research is a specialized clinical trial site and contract research organization (CRO) based in Toronto, Canada. Led by Dr. Gordon Sussman, a world-renowned expert in allergy and clinical immunology, the center conducts Phase 1 through Phase 4 clinical trials for global pharmaceutical and biotechnology sponsors. The organization focuses primarily on immunological and dermatological conditions, including chronic urticaria, hereditary angioedema, and severe asthma. It provides comprehensive site services such as patient recruitment, trial management, and specialized diagnostic testing. The facility is recognized for its contribution to the clinical development of major allergy and immunology therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gordon Sussman Clinical Research.